Table 3.
A. Size difference (mm) prior to pupil observations | NOA (M=138) vs. No NOA (M=3487) | |
---|---|---|
| ||
Diff Size | OR [95% CI] | p |
| ||
One observation prior (N=191, M=3282) | 10.34 [5.08, 20.80] | <0.001* |
Two observations prior (N=167 M=2898) | 6.99 [3.09, 15.45] | <0.001* |
Three observations prior (N=146, M=2314) | 6.04 [2.40, 14.77] | <0.001* |
Four observations prior (N=123, M=1773) | 13.27 [4.65, 36.95] | <0.001* |
| ||
B. Minimum NPi prior to FT-NOA pupil observations | NOA-Abnormal (M=44) vs. NOA-Normal (M=94) | |
| ||
Min NPi | OR [95% CI] | p |
| ||
One observation prior (N=107, M=107) | 0.25 [0.12, 0.45] | <0.001* |
Two observations prior (N=88, M=88) | 0.26 [0.11, 0.47] | <0.001* |
Three observations prior (N=69, M=69) | 0.21 [0.07, 0.44] | <0.001* |
Four observations prior (N=52, M=52) | 0.24 [0.07, 0.53] | 0.004* |
Panel A reports univariate mixed effects logistic regression models to account for inter-subject variability testing first-time NOA and size difference up to four observations prior. Panel B reports univariate logistic regression for first-time NOA phenotype and minimum NPi. All models adjust for GCS and osmotic medications prior to observation. Abbreviations: OR = Odds Ratio, CI = Confidence Interval, NOA = New Onset Anisocoria, FT-NOA = First-Time NOA, N=patients, M=observations. Observational sample sizes are included in Supplementary Methods.